Article Text

Download PDFPDF
Burning Mouth Syndrome: Current Clinical, Physiopathologic, and Therapeutic Data
  1. Déborah Ducasse, MD*,
  2. Philippe Courtet, MD, PhD, Pr and
  3. Emilie Olie, MD
  1. *Department of Psychiatric Emergency, Hôpital Lapeyronie, CHU Montpellier; †Université Montpellier 1; and ‡Inserm U1061, Montpellier, France.
  1. Address correspondence to: Déborah Ducasse, Département d'Urgences et Post-urgences Psychiatriques, Hôpital Lapeyronie, CHU Montpellier, 191, avenue du Doyen Gaston Giraud, 34295 Montpellier cedex 5, France (e-mail: d-ducasse{at}chu-montpellier.fr).

Abstract

Abstract Primary burning mouth syndrome (BMS) is defined as an “intraoral burning for which no medical or dental cause was found.” Lifetime prevalence ranges from 3.7% to 18% – 40% in the elderly. There is no consensus among experts on the diagnostic criteria of BMS, the etiology is poorly understood, and there are no existing clinical guidelines. Therefore, BMS is often underdiagnosed and its management complex. For patients with BMS, this lack of clinical expertise may result in decreased quality of life and increased psychological distress.

We conducted a systematic review to identify clinical features, pathophysiology, and therapeutic strategies for BMS. We discuss the multifactorial origin, involving peripheral nerve dysfunction and hormonal dysfunction, as well as psychological traits. We also describe the results of randomized clinical trials for each treatment through a pathophysiologic approach. This review should help clinicians recognize BMS, understand its pathophysiology, and gain an enhanced scientific understanding of therapeutic alternatives.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • The authors declare no conflict of interest.

    This review was presented in part at the 21st European Congress of Psychiatry in Nice, France, April 6–9, 2013.